Advertisement

Infective Endocarditis

  • Harbir Arora
  • Eric McGrath
  • Basim I. Asmar
Chapter

Abstract

Among children the incidence of infective endocarditis (IE) is highest in those with congenital heart disease. The use of prosthetic devices for correcting heart defects and prolonged use of central venous catheters are major risk factors.

Staphylococcus aureus has replaced viridans group Streptococcus as the most common cause of IE in children older than 1 year. Gram-negative oropharyngeal flora, so-called AACEK (previously HACEK) organisms, is a less common cause. Nutritionally variant streptococci, now comprised of Abiotrophia species, can rarely cause IE.

IE can present as subacute illness progressing over a few weeks or as acute illness with sepsis-like presentation. Physical signs are mainly the manifestations of valvular damage, embolic phenomenon, and immune complex-mediated involvement of different body systems. The hallmark diagnosis of IE is serial positive blood cultures obtained, over a period of time, from different venipuncture sites.

Echocardiography is paramount to evaluating IE. Two-dimensional imaging can detect vegetations as small as 2 mm. Transthoracic echocardiography is adequate for initial rapid imaging. Transesophageal echocardiography can be more useful in evaluating patients with complex congenital cardiac anatomy.

The Modified Duke Criteria can help make or reject the diagnosis of IE. Major criteria are based on blood cultures and echocardiography results. Minor criteria are based on predisposing heart conditions, fever, and signs of vascular and immunologic phenomena.

Patients with life-threatening IE can develop heart failure and may have sepsis-like presentation. The most urgent evaluation in the emergency department (ED) is hemodynamic status. If heart failure is suspected, echocardiography and several closely spaced blood cultures should be obtained without delay. Hemodynamic support and transfer to a critical care unit may be necessary.

Presumptive antibiotic treatment is based on the patient’s age, clinical presentation, preexisting cardiac status, recent surgery, and local antimicrobial sensitivity. Reviewing and defining the choice of parenteral therapy with an infectious disease specialist is warranted. Comprehensive treatment guidelines are issued and updated by the American Heart Association.

In the ED, immediate consultation with cardiology and cardiovascular surgery may be warranted in patients with left-sided native valve endocarditis, prosthetic valve endocarditis, heart failure, and recurrent emboli and those with tricuspid valve vegetation at least 20 mm in diameter.

Keywords

Infective endocarditis in children Endocarditis microbiology Endocarditis diagnosis Endocarditis treatment Endocarditis complications 

References

  1. 1.
    Awadallah SM, Kavey RE, Byrum CJ, Smith FC, Kveselis DA, Blackman MS. The changing pattern of infective endocarditis in childhood. Am J Cardiol. 1991;68:90–4.CrossRefGoogle Scholar
  2. 2.
    Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Pediatrics. 2002;109:931–43.CrossRefGoogle Scholar
  3. 3.
    Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009;119:865–70.CrossRefGoogle Scholar
  4. 4.
    Rosenthal LB, Feja KN, Levasseur SM, Alba LR, Gersony W, Saiman L. The changing epidemiology of pediatric endocarditis at a children’s hospital over seven decades. Pediatr Cardiol. 2010;31:813–20.CrossRefGoogle Scholar
  5. 5.
    Johnson JA, Boyce TG, Cetta F, Steckelberg JM, Johnson JN. Infective endocarditis in the pediatric patient: a 60-year single-institution review. Mayo Clin Proc. 2012;87:629–35.CrossRefGoogle Scholar
  6. 6.
    Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.CrossRefGoogle Scholar
  7. 7.
    Gupta S, Sakhuja A, McGrath E, Asmar B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000–2010 in the United States. Congenit Heart Dis. 2017;12:196–201.CrossRefGoogle Scholar
  8. 8.
    Coward K, Tucker N, Darville T. Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr Infect Dis J. 2003;22:1048–52.CrossRefGoogle Scholar
  9. 9.
    Baltimore RS, Gewitz M, Baddour LM, et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015;132:1487–515.CrossRefGoogle Scholar
  10. 10.
    Stull TL, Lipuma JJ. Endocarditis in children. 2nd ed. New York: Raven Press; 1992.Google Scholar
  11. 11.
    Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847–53.CrossRefGoogle Scholar
  12. 12.
    Rushani D, Kaufman JS, Ionescu-Ittu R, et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation. 2013;128:1412–9.CrossRefGoogle Scholar
  13. 13.
    Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA. 1998;279:599–603.CrossRefGoogle Scholar
  14. 14.
    Daher AH, Berkowitz FE. Infective endocarditis in neonates. Clin Pediatr (Phila). 1995;34:198–206.CrossRefGoogle Scholar
  15. 15.
    Oelberg DG. Neonatal endocarditis–neither rare nor fatal. Clin Pediatr (Phila). 1998;37:747–8.CrossRefGoogle Scholar
  16. 16.
    Opie GF, Fraser SH, Drew JH, Drew S. Bacterial endocarditis in neonatal intensive care. J Paediatr Child Health. 1999;35:545–8.CrossRefGoogle Scholar
  17. 17.
    Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363:139–49.CrossRefGoogle Scholar
  18. 18.
    Alshammary A, Hervas-Malo M, Robinson JL. Pediatric infective endocarditis: has Staphylococcus aureus overtaken viridans group streptococci as the predominant etiological agent? Can J Infect Dis Med Microbiol. 2008;19:63–8.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Feder HM Jr, Roberts JC, Salazar J, Leopold HB, Toro-Salazar O. HACEK endocarditis in infants and children: two cases and a literature review. Pediatr Infect Dis J. 2003;22:557–62.PubMedGoogle Scholar
  20. 20.
    Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis. 1998;27:1451–6.CrossRefGoogle Scholar
  21. 21.
    Levasseur SS, Saiman L. Endocarditis and other intravascular infections. In: Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious diseases. 4th ed. Philadelphia: Elsevier Saunders; 2012. p. 256–65.Google Scholar
  22. 22.
    Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;132:1435–86.CrossRefGoogle Scholar
  23. 23.
    Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.CrossRefGoogle Scholar
  24. 24.
    Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefGoogle Scholar
  25. 25.
    Tan M, Armstrong D, Birken C, et al. Bacterial endocarditis in a child presenting with acute arterial ischemic stroke: should thrombolytic therapy be absolutely contraindicated? Dev Med Child Neurol. 2009;51:151–4.CrossRefGoogle Scholar
  26. 26.
    Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69–75.CrossRefGoogle Scholar
  27. 27.
    Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44:364–72.CrossRefGoogle Scholar
  28. 28.
    Cabell CH, Abrutyn E, Fowler VG Jr, et al. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J. 2005;150:1092–8.CrossRefGoogle Scholar
  29. 29.
    Wang A, Pappas P, Anstrom KJ, et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005;150:1086–91.CrossRefGoogle Scholar
  30. 30.
    Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138:739–45; 47–60.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Harbir Arora
    • 1
    • 2
  • Eric McGrath
    • 1
    • 2
  • Basim I. Asmar
    • 1
    • 2
  1. 1.Department of PediatricsWayne State University School of MedicineDetroitUSA
  2. 2.Division of Infectious DiseasesChildren’s Hospital of MichiganDetroitUSA

Personalised recommendations